RSU settlement: MapLight Therapeutics (NASDAQ: MPLT) vested 7,305 shares

Rhea-AI Filing Summary

MapLight Therapeutics reported the settlement of 7,305 restricted stock units into MapLight voting common stock on 04/15/2026. The filing states the units were a vested grant settled in stock and the consideration was the reporting person’s continued service as an employee.

Insights

Securities Compliance

Notice documents a routine RSU settlement by an insider.

The filing records a vested restricted stock unit settlement of 7,305 shares into voting common stock on 04/15/2026. It identifies the consideration as the reporting person’s continued service, indicating a compensation-related conversion rather than an open-market sale.

Cash‑flow treatment and any subsequent sale plans are not stated in the excerpt; subsequent filings would show any intended disposition.

Key Figures

RSUs settled: 7,305 shares Settlement date: 04/15/2026

2 metrics

RSUs settled 7,305 shares vested grant settled in stock on 04/15/2026

Settlement date 04/15/2026 date of RSU settlement into voting common stock

Key Terms

Restricted stock unit, Vested grant, Form 144

3 terms

Restricted stock unit financial

"Restricted stock unit settlement | MapLight Therapeutics, Inc."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Vested grant financial

"Vested grant settled in stock; consideration was Reporting Person's continued service"

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 05:15 PM Learn about SEC filing dates

FAQ

What did MapLight Therapeutics (MPLT) report in this Form 144?

The filing reports a settlement of 7,305 restricted stock units into common stock on 04/15/2026. The excerpt says the units were a vested grant and the consideration was continued service as an employee.

Does the Form 144 show proceeds or a sale amount for MPLT shares?

No — the excerpt does not state any sale proceeds or market transaction details. It only records an RSU settlement into voting common stock on 04/15/2026.

Who received the shares reported in the MPLT filing?

The reporting person received 7,305 shares via settlement of vested RSUs. The filing attributes the consideration to the reporting person’s continued service as an employee.

Was the RSU settlement described as a sale or market transaction?

No — the excerpt describes a vested grant settled in stock, not an open-market sale. The document does not describe any brokered sale or disposition in the provided text.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
MapLight voting common stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 8th Floor New York NY 10004	4000	108080.00	42436326	04/15/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
MapLight voting common stock	04/15/2026	Restricted stock unit settlement	MapLight Therapeutics, Inc.			7305	04/15/2026	Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)